Together, these observations identify PCSK9 as a mechanistic link between systemic metabolic state and peripheral nerve integrity, and they highlight the need for targeted studies of PCSK9 in neuropathies associated with diabetes, obesity, and dyslipidemia. This evidence concerns the gene PCSK9 and neuropathy.